Destination Maternity (DESTQ) 10-Q 12 Jun 19 2019 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	May 04, 2019	Jun. 03, 2019
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	May 4, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q1
Trading Symbol	DEST
Entity Registrant Name	Destination Maternity Corp
Entity Central Index Key	0000896985
Current Fiscal Year End Date	--02-01
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		14,339,786

CONSOLIDATED BALANCE SHEETS (un

CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($) $ in Thousands	May 04, 2019	Feb. 02, 2019
Current assets:
Cash and cash equivalents	$ 1,193	$ 1,154
Trade receivables, net	8,807	7,945
Inventories	72,133	70,872
Prepaid expenses and other current assets	9,855	9,407
Total current assets	91,988	89,378
Property and equipment, net of accumulated depreciation and amortization of $108,556 and $106,479	50,510	51,483
Operating lease assets	128,065
Deferred income taxes	3,314	2,671
Other non-current assets	1,918	2,642
Total assets	275,795	146,174
Current liabilities:
Line of credit borrowings	26,200	20,400
Current portion of long-term debt	4,257	4,372
Accounts payable	21,355	21,854
Operating lease liabilities	32,327
Accrued expenses and other current liabilities	24,608	31,056
Total current liabilities	108,747	77,682
Long-term debt	22,294	21,784
Operating lease and other non-current liabilities	119,938	19,557
Total liabilities	250,979	119,023
Commitments and contingencies (Note 16)
Stockholders’ equity:
Preferred stock, 1,656,381 shares authorized, none outstanding
Common stock, $.01 par value; 20,000,000 shares authorized, 14,375,658 and 14,416,500 shares issued and outstanding	144	144
Additional paid-in capital	107,785	107,675
Accumulated deficit	(83,039)	(80,594)
Accumulated other comprehensive loss	(74)	(74)
Total stockholders’ equity	24,816	27,151
Total liabilities and stockholders’ equity	$ 275,795	$ 146,174

CONSOLIDATED BALANCE SHEETS (_2

CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical) - USD ($) $ in Thousands	May 04, 2019	Feb. 02, 2019
Statement Of Financial Position [Abstract]
Property and equipment, accumulated depreciation and amortization	$ 108,556	$ 106,479
Preferred stock, shares authorized	1,656,381	1,656,381
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	20,000,000	20,000,000
Common stock, shares issued	14,375,658	14,416,500
Common stock, shares outstanding	14,375,658	14,416,500

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	May 04, 2019	May 05, 2018
Income Statement [Abstract]
Net sales	$ 94,213	$ 103,227
Type of Revenue [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember
Cost of goods sold	$ 42,616	$ 47,824
Type of Cost, Good or Service [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember
Gross profit	$ 51,597	$ 55,403
Selling, general and administrative expenses	48,490	51,857
Store closing, asset impairment and asset disposal expenses	869	969
Other charges	662	1,150
Operating income	1,576	1,427
Interest expense, net	1,415	1,157
Income before income taxes	161	270
Income tax provision	31	56
Net income	$ 130	$ 214
Net income per share— Basic	$ 0.01	$ 0.02
Average shares outstanding— Basic	13,825	13,839
Net income per share— Diluted	$ 0.01	$ 0.02
Average shares outstanding— Diluted	13,901	13,963

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (unaudited) - USD ($) $ in Thousands	3 Months Ended
	May 04, 2019	May 05, 2018
Statement Of Income And Comprehensive Income [Abstract]
Net income	$ 130	$ 214
Comprehensive income	$ 130	$ 214

CONSOLIDATED STATEMENTS OF STOC

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Beginning Balance at Feb. 03, 2018	$ 40,668	$ 147	$ 106,865	$ (66,274)	$ (70)
Beginning Balance, shares at Feb. 03, 2018		14,684
Net income	214			214
Dividends forfeited	1			1
Stock-based compensation	328	$ 4	324
Stock-based compensation, shares		383
Repurchase and retirement of common stock	(19)	$ (1)	(18)
Repurchase and retirement of common stock, shares		(62)
Ending Balance at May. 05, 2018	41,192	$ 150	107,171	(66,059)	(70)
Ending Balance, shares at May. 05, 2018		15,005
Beginning Balance at Feb. 02, 2019	27,151	$ 144	107,675	(80,594)	(74)
Beginning Balance, shares at Feb. 02, 2019		14,417
Adoption of ASC 842 - Leases | ASC 842	(2,576)			(2,576)
Net income	130			130
Dividends forfeited	1			1
Stock-based compensation	144	$ 1	143
Stock-based compensation, shares		75
Repurchase and retirement of common stock	(34)	$ (1)	(33)
Repurchase and retirement of common stock, shares		(116)
Ending Balance at May. 04, 2019	$ 24,816	$ 144	$ 107,785	$ (83,039)	$ (74)
Ending Balance, shares at May. 04, 2019		14,376

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($) $ in Thousands	3 Months Ended
	May 04, 2019	May 05, 2018
Operating Activities
Net income	$ 130	$ 214
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization	3,553	4,050
Stock-based compensation expense	144	328
Loss on impairment of long-lived assets	562	887
Loss on disposal of assets	188	13
Grow NJ award benefit	(643)	(707)
Amortization of deferred financing costs	177	165
Decrease (increase) in:
Trade receivables	(862)	(2,197)
Inventories	(1,261)	4,837
Prepaid expenses and other current assets	(448)	(252)
Operating leases and other non-current assets	6,317	(14)
Decrease in:
Accounts payable, accrued expenses, operating leases and other current liabilities	(4,931)	(9,031)
Operating leases and other non-current liabilities	(7,522)	(752)
Net cash used in operating activities	(4,596)	(2,459)
Investing Activities
Capital expenditures	(2,478)	(1,141)
Net cash used in investing activities	(2,478)	(1,141)
Financing Activities
Decrease in cash overdraft	1,106	(1,980)
Increase in line of credit borrowings	5,800	7,200
Proceeds from long-term debt	1,802
Repayment of long-term debt	(1,562)	(1,151)
Deferred financing costs paid		(80)
Withholding taxes on stock-based compensation paid in connection with repurchase of common stock	(33)	(19)
Net cash provided by financing activities	7,113	3,970
Net Increase in Cash and Cash Equivalents	39	370
Cash and Cash Equivalents, Beginning of Period	1,154	1,635
Cash and Cash Equivalents, End of Period	1,193	2,005
Supplemental Disclosures of Cash Flow Information:
Cash paid for interest	1,218	$ 968
Cash received for income taxes	$ (198)

Basis of Financial Statement Pr

Basis of Financial Statement Presentation	3 Months Ended
	May 04, 2019
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Basis of Financial Statement Presentation	1. BASIS OF FINANCIAL STATEMENT PRESENTATION The accompanying unaudited consolidated financial statements for the three months ended May 4, 2019 and May 5, 2018 have been prepared in accordance with the requirements for Form 10-Q and Article 10 of Regulation S-X, and accordingly, certain information and footnote disclosures have been condensed or omitted. See the Company’s Annual Report on Form 10-K as of and for the year ended February 2, 2019 for Destination Maternity Corporation and subsidiaries (the “Company” or “Destination Maternity”) as filed with the Securities and Exchange Commission (“SEC”) for additional disclosures, including a summary of the Company’s accounting policies. In the opinion of management, the consolidated financial statements contain all adjustments, consisting of normal recurring adjustments, necessary to present fairly the consolidated financial position, results of operations and cash flows of the Company for the periods presented. Since the Company’s operations are seasonal, the interim operating results of the Company may not be indicative of operating results for the full year. Certain prior year amounts have been reclassified to conform to current year presentation. The Company operates on a 52/53-week fiscal year ending on the Saturday nearest January 31 of each year. References to the Company’s fiscal 2019 refer to the 52-week fiscal year, or periods within such fiscal year, which began February 3, 2019 and will end February 1, 2020. References to the Company’s fiscal 2018 refer to the 52-week fiscal year, or periods within such fiscal year, which began February 4, 2018 and ended February 2, 2019.

Earnings Per Share ("EPS")

Earnings Per Share ("EPS")	3 Months Ended
	May 04, 2019
Earnings Per Share [Abstract]
Earnings Per Share (“EPS”)	2. EARNINGS PER SHARE (“EPS”) Basic net income per share (“Basic EPS”) is computed by dividing net income by the weighted average number of common shares outstanding, excluding restricted stock awards for which the restrictions have not lapsed. Diluted net income per share (“Diluted EPS”) is computed by dividing net income by the weighted average number of common shares outstanding, after giving effect to the potential dilution, if applicable, from the assumed lapse of restrictions on restricted stock and restricted stock unit (“RSU”) awards, and from shares of common stock resulting from the assumed exercise of outstanding stock options. Common shares issuable in connection with the award of performance-based restricted stock units (“PRSUs”) are excluded from the calculation of EPS until the PRSUs’ performance conditions are achieved and the shares in respect of the PRSUs become issuable (see Note 14). The following tables summarize the Basic EPS and Diluted EPS calculations (in thousands, except per share amounts): Three Months Ended May 4, 2019 May 5, 2018 Net Income Shares EPS Net Income Shares EPS Basic EPS $ 130 13,825 $ 0.01 $ 214 13,839 $ 0.02 Incremental shares from the assumed exercise of outstanding stock options — — — — — — Incremental shares from the assumed lapse of restrictions on restricted stock and RSU awards — 76 — — 124 — Diluted EPS $ 130 13,901 $ 0.01 $ 214 13,963 $ 0.02 Stock options and unvested restricted stock totaling 959,000 shares of the Company’s common stock were outstanding as of May 4, 2019, of which 610,000 shares were excluded from the calculation of Diluted EPS as the effect would have been antidilutive.

Trade Receivables

Trade Receivables	3 Months Ended
	May 04, 2019
Receivables [Abstract]
Trade Receivables	3. TRADE RECEIVABLES Trade receivables are recorded based on revenue recognized for sales of the Company’s merchandise and for other revenue earned by the Company through its marketing partnership programs and international franchise agreements, and are non-interest bearing. The Company evaluates the collectability of trade receivables based on a combination of factors, including aging of trade receivables, write-off experience, analysis of historical trends and expectations of future performance. An allowance for doubtful accounts is recorded for the amount of trade receivables that are considered unlikely to be collected. When the Company’s collection efforts are unsuccessful, uncollectible trade receivables are charged against the allowance for doubtful accounts. As of May 4, 2019 and February 2, 2019, the Company’s trade receivables were net of allowance for doubtful accounts of $166,000 and $166,000, respectively.

Inventories

Inventories	3 Months Ended
	May 04, 2019
Inventory Disclosure [Abstract]
Inventories	4. INVENTORIES Inventories were comprised of the following (in thousands): May 4, 2019 February 2, 2019 Finished goods $ 71,992 $ 70,660 Work-in-progress 46 148 Raw materials 95 64 Total $ 72,133 $ 70,872

Accrued Expenses and Other Curr

Accrued Expenses and Other Current Liabilities	3 Months Ended
	May 04, 2019
Payables And Accruals [Abstract]
Accrued Expenses and Other Current Liabilities	5. ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES Accrued expenses and other current liabilities were comprised of the following (in thousands): May 4, 2019 February 2, 2019 Employee compensation and benefits $ 4,376 $ 6,741 Insurance, primarily self-insurance reserves 3,125 3,049 Sales and use taxes 3,086 2,737 Accrued expenses 3,073 4,561 Gift certificates and store credits 2,915 3,464 Product return reserve 2,530 2,078 Deferred revenue 1,713 2,435 Audit and legal 1,463 1,341 Deferred rent — 3,101 Other 2,327 1,549 Total $ 24,608 $ 31,056

Line of Credit

Line of Credit	3 Months Ended
	May 04, 2019
Debt Disclosure [Abstract]
Line of Credit	6. LINE OF CREDIT After completion of a debt refinancing on February 1, 2018, the Company has in place a $50,000,000 senior secured revolving credit facility (the “Credit Facility”), which was entered into in conjunction with the issuance of the Company’s $25,000,000 Term Loan (as defined below) (see Note 7). Proceeds from advances under the Credit Facility, subject to certain restrictions, may be used to provide financing for working capital, letters of credit, capital expenditures, and other general corporate purposes The Credit Facility, which matures on January 31, 2023, contains various affirmative and negative covenants and representations and warranties, including the requirement that the Company maintain Excess Availability (as defined in the related Credit Agreement) of more than the greater of 10% of the Combined Loan Caps (as defined in the related Credit Agreement) and $7,000,000. In the event that the outstanding balance of the Term Loan exceeds the Term Loan Borrowing Base (as defined in the related Term Loan Agreement), then a reserve will be imposed against availability under the Credit Facility. The Credit Facility is secured by a security interest in the Company’s trade receivables, inventory, letter of credit rights, cash, intangibles and certain other assets. The interest rate on outstanding borrowings is equal to, at the Company’s election, either 1) the lender’s base rate plus 0.50% or 2) a LIBOR rate plus 1.0%. The Company also pays an unused line fee under the Credit Facility of 0.25% per annum. Any amounts outstanding under the Credit Facility may be accelerated and become due and payable immediately and all loan and letter of credit commitments thereunder may be terminated upon an event of default and expiration of any applicable cure period. Events of default include: 1) nonpayment of obligations due under the subject loan agreement and related loan documents, 2) cross-defaults to other indebtedness and documents, 3) failure to perform any covenant or agreement contained in the subject loan agreement, 4) material misrepresentations, 5) failure to pay, or certain other defaults under, other material indebtedness of the Company, 6) certain bankruptcy or insolvency events, 7) a change of control, 8) indictments of the Company or senior management in a material forfeiture action, 9) default under certain material contracts to the extent such termination or default has or could reasonably be expected to have a material adverse effect, and 10) customary ERISA defaults, among others. In connection with the original execution and subsequent amendments of the Credit Facility, the Company has incurred deferred financing costs of $1,281,000. These deferred financing costs are being amortized over the term of the Credit Facility agreement and are included in “interest expense, net” in the consolidated statements of operations. As of May 4, 2019, the Company had $26,200,000 in outstanding borrowings under the Credit Facility, $6,297,000 in letters of credit and $10,128,000 of availability based on the Company’s Borrowing Base formula and availability reserve requirements. As of May 5, 2018, the Company had $15,200,000 in outstanding borrowings under the Credit Facility, $7,327,000 in letters of credit and $20,223,000 of availability. For the three months ended May 4, 2019 and May 5, 2018 borrowings had a weighted interest rate of 4.53% and 3.60% per annum, respectively.

Long-Term Debt

Long-Term Debt	3 Months Ended
	May 04, 2019
Debt Disclosure [Abstract]
Long-Term Debt	7. LONG-TERM DEBT On February 1, 2018 (the “Closing Date”), t he Company has entered into a Term Loan Credit Agreement (the “Term Loan Agreement”) which provides for a term loan of up to $25,000,000 and matures on January 31, 2023 (the “Term Loan”). On the Closing Date, the Company borrowed $22,500,000. The Term Loan provided for an additional loan of $2,500,000, which could be borrowed at the Company’s discretion within a period of 45 days after delivery to the lender of the Company’s first quarter fiscal 2018 financial statements and satisfaction of certain other requirements. The Company met these requirements and borrowed the additional $2,500,000 on July 16, 2018. The interest rate on the Term Loan is equal to a LIBOR rate plus 9.0%. The Company is required to make minimum repayments of the principal amount of the Term Loan in quarterly installments of $312,500 which commenced on July 31, 2018, with the remaining outstanding balance payable on the maturity date. There is a minimum excess availability requirement of the greater of 10% of the Combined Loan Cap, as defined in the Term Loan Agreement, or $7,000,000. Additionally, the Term Loan can be prepaid at the Company’s option subject to certain restrictions and subject to a prepayment premium as follows: 1) if the prepayment occurs on or prior to the second anniversary of the Closing Date, the greater of a) interest on the prepayment that would otherwise have been paid with the 24 month period following the Closing Date minus actual interest payments made through the prepayment date and b) 2% of the prepayment and 2) 2% of the prepayment amount, if paid between the second and third anniversary of the Closing Date. The Term Loan is secured by a security interest in substantially all of the assets of the Company, including accounts receivable, inventory, equipment, letter of credit rights, cash, intellectual property and other intangibles, and certain other assets. The security interest granted to the Term Lenders is, in certain respects, subordinate to the security interest granted to the Credit Facility Lender. The Term Loan Agreement prohibits the payment of dividends or share repurchases by the Company for three years and imposes certain restrictions on the Company’s ability to, among other things, incur additional indebtedness and enter into other various types of transactions. There were $2,455,000 of deferred financing costs incurred in connection with the Term Loan. These deferred financing costs are reflected as a direct deduction from the Term Loan liability in the consolidated balance sheets and are being amortized over the term of the Term Loan Agreement. The amortization is included in “interest expense, net” in the consolidated statements of operations. As of May 4, 2019 and May 5, 2018, there was $23,750,000 and $22,500,000, respectively, of principal outstanding under the Term Loan. On February 22, 2019, the Company entered into a 24-month, $1,802,000 software development financing arrangement. The note has monthly payments of $81,648 with an interest rate of 8.16%. As of May 4, 2019, there was $1,593,000 of principal outstanding. As of May 4, 2019 and May 5, 2018, there was $2,149,000 and $5,284,000, respectively, outstanding under a five-year equipment financing arrangement with the Company’s Credit Facility bank. The equipment note bears annual interest at 3.38%, with payments of $272,000 (including interest) due monthly through December 2019. The equipment note is collateralized by substantially all of the material handling equipment at the Company’s distribution facility in Florence, New Jersey. Any amounts outstanding under the equipment note may be accelerated and become due and payable immediately upon an event of default and expiration of any applicable cure period. The specified events of default are substantially the same as those in the Credit Facility agreement (see Note 6). On June 6, 2017, the Company received $3,401,000 in proceeds from a three-year financing arrangement in the form of a sale and leaseback for certain furniture, fixtures and software. Monthly payments under the leaseback arrangement are $123,000 for the first 24 months and $48,000 for months 25 to 36. At the end of the leaseback term, the Company has the option to extend the lease for an additional year or to repurchase the financed property for a price to be agreed upon. As of May 4, 2019, and May 5, 2018, there was $1,114,000 and $2,287,000 of principal outstanding under this financing arrangement.

Leases

Leases	3 Months Ended
	May 04, 2019
Lessee Disclosure [Abstract]
Leases	8. LEASES The Company has entered into operating leases for all of its retail locations, distribution center and corporate office. Many of these leases include one or more renewal options which can extend the lease for up to an additional 15 years. Finance leases were not material as of May 4, 2019 and the three-month period then ended. For the three months ended May 4, 2019, the components of lease expense were as follows (in thousands): Fixed operating lease expense (1) $ 8,743 Variable operating lease expense 3,893 Total operating lease expense $ 12,636 (1) Includes short-term leases. For the three months ended May 5, 2018, rent expense, including related occupancy costs such as insurance and maintenance paid to landlords, for non-cancellable operating leases amounted to $12.8 million. The following table presents the operating lease balances within the Consolidated Balance Sheet, weighted average remaining lease term and weighted average discount rates related to the Company’s operating leases as of May 4, 2019 ($ in thousands): Lease Assets and Liabilities Classification Assets: Operating lease ROU assets Operating lease assets $ 128,065 Liabilities: Current: Operating lease liabilities Operating lease liabilities $ 32,327 Long-term: Operating lease liabilities Operating lease and other non-current liabilities 119,636 Total undiscounted operating lease liabilities $ 151,963 Weighted average remaining lease term 6.4 years Weighted average discount rate 7.40 % The following table presents the maturity of the Company’s operating lease liabilities as of May 4, 2019 (in thousands): Remainder of Fiscal 2019 $ 32,864 2020 34,750 2021 28,555 2022 24,128 2023 20,969 Thereafter 53,693 Total operating lease payments 194,959 Less: Imputed interest 42,996 Total operating lease liabilities $ 151,963 The following table presents future minimum lease payments as previously disclosed in our 2018 Annual Report on Form 10-K determined using the previous lease accounting standard. 2019 $ 36,417 2020 29,682 2021 21,142 2022 21,698 2023 15,995 Thereafter 48,462 Total operating lease liabilities $ 173,396 Supplemental cash flow information related to the Company’s operating leases for the three months ended May 4, 2019 (in thousands): Cash paid for amounts included in the measurement of operating lease liabilities $ 11,994 ROU assets obtained in exchange for operating lease liability 1,829

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	May 04, 2019
Fair Value Disclosures [Abstract]
Fair Value Measurements	9 . FAIR VALUE MEASUREMENTS The accounting standard for fair value measurements defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The standard establishes a framework for measuring fair value focused on exit price and creates a fair value hierarchy in order to increase the consistency and comparability of fair value measurements as follows: • Level 1 – Quoted market prices in active markets for identical assets or liabilities • Level 2 – Observable market-based inputs or inputs that are corroborated by observable market data • Level 3 – Unobservable inputs that are not corroborated by market data At both May 4, 2019 and February 2, 2019, the Company had cash equivalents of $4,000. The Company’s cash equivalents consist of investments in money market funds for which the carrying value approximates fair value (based on Level 1 inputs) due to the short-term nature of those instruments. The carrying values of trade receivables and accounts payable approximate fair value due to the short-term nature of those instruments. The Company’s Credit Facility has variable interest rates that are tied to market indices. As of May 4 , 2019 and February 2, 2019, The Company’s Term Loan, which represents a significant majority of the Company’s long-term debt, bears interest at variable rates, which adjust based on market conditions with a minimum annual rate of 9.00%. The carrying value of the Company’s Term Loan approximates fair value as the variable interest rates approximate current market rates for similar instruments available to companies with comparable credit quality, which the Company considers to be Level 2 inputs. The fair value of the Company’s fixed-rate equipment notes were determined using a discounted cash flow analysis based on interest rates currently available to the Company, which the Company considers to be Level 2 inputs. The difference between the carrying value and fair value of long-term debt held by the Company with a fixed rate of interest is not material.

Net Sales

Net Sales	3 Months Ended
	May 04, 2019
Revenues [Abstract]
Net Sales	10 . NET SALES The following disaggregates the Company’s net sales by major source (in thousands): Three Months Ended May 4, 2019 May 5, 2018 Retail stores $ 56,464 $ 62,987 Leased departments 9,348 9,989 Total retail locations 65,812 72,976 E-commerce 22,672 25,482 Marketing partnerships 4,580 3,935 Wholesale and franchise 1,150 834 Total net sales $ 94,213 $ 103,227

Other Charges

Other Charges	3 Months Ended
	May 04, 2019
Other Charges Related To Management And Organizational Changes And Proxy Solicitation [Abstract]
Other Charges	1 1 . OTHER CHARGES O ver the last several years the Company has engaged in a series of management and organizational changes and, in connection therewith, retained consulting firms to review its costs and business strategy associated with such management and organizational changes. The Company’s Board of Directors authorized changes to the Company’s chief executive function, including, most recently, the May 23, 2018 appointment of Marla Ryan as Chief Executive Officer, who replaced Melissa Payner-Gregor who had served as interim Chief Executive Officer since January 2, 2018. Ronald Masciantonio, the Company’s Chief Administrative Officer, resigned from his position on June 4, 2018. David Stern, the Company’s former Chief Financial Officer, departed the Company effective at the close of business on August 10, 2018. On January 19, 2019, Dave J. Helkey was appointed Chief Operating Officer and Chief Financial Officer. The Company also paid one-time retention bonuses with service conditions to certain key management personnel which are being recorded over the service period, while reducing its overall headcount to create a more efficient and effective operating structure. In the first quarter of fiscal 2018, the Company received notification from a stockholder group of their intent to nominate a slate of alternative nominees for election to the Company’s Board of Directors at the Annual Meeting of Stockholders that was held on May 23, 2018 (the “Proxy Solicitation”). At the 2018 Annual Meeting of Stockholders the Company’s stockholders replaced the incumbent board in its entirety and elected Holly N. Alden, Christopher B. Morgan, Marla A Ryan and Anne-Charlotte Windal as the Company’s new Board of Directors . A summary of charges incurred in connection with management and organizational changes and the proxy solicitation is as follows (in thousands): Three Months Ended May 4, 2019 May 5, 2018 Management and organizational changes $ 662 $ 264 Proxy solicitation — 886 Total other charges $ 662 $ 1,150

Government Incentives

Government Incentives	3 Months Ended
	May 04, 2019
Government Incentives Disclosure [Abstract]
Government Incentives	1 2 . GOVERNMENT INCENTIVES In fiscal 2015, the Company completed the relocation of its corporate headquarters and distribution operations from Philadelphia, Pennsylvania to southern New Jersey. To partially offset the costs of these relocations, the Board of the New Jersey Economic Development Authority (“NJEDA”) approved the Company for an incentive package of up to $40,000,000 in benefits under the Grow New Jersey Assistance Program (“Grow NJ”) in the form of transferrable income tax credits over a ten-year period from the State of New Jersey. The award provides annually over a ten-year period up to $7,000 per eligible new full-time job, as defined under Grow NJ, with a requirement that at least 100 eligible jobs be created and subject to an annual award limit of $4,000,000. The Grow NJ award requires an annual compliance report that includes certification of average annual employment figures after the end of each fiscal year. After the end of the ten-year Grow NJ award earnings period there is a five-year compliance period during which the Company must maintain the average of its annual eligible jobs certified during the preceding ten years or a pro-rata amount up to one-tenth of the previously awarded income tax credits would be subject to recapture and repayment to the State of New Jersey annually during the five-year compliance period. The Company believes the likelihood of any recapture and repayment is remote. The annual benefit from the Grow NJ award available to the Company is expected to significantly exceed the Company’s annual income tax liability to the State of New Jersey. In order to maximize the realizable value of the incentive package, the Company entered into an agreement with a third party to sell up to 100% of the annual income tax credits awarded to the Company. The Company recognizes its Grow NJ award on an annual basis for each fiscal year based on the realizable value of the award earned and expected to be received, primarily from the sale of the income tax credits, net of any associated costs. The Grow NJ award is reflected in the Company’s consolidated financial statements as a reduction to the costs incurred by the Company in connection with the relocations. The expected realizable amount of the Grow NJ award is included in the consolidated balance sheet in deferred income taxes. As of May 4, 2019, the Company had recorded a deferred tax asset of $3,314,000 related to the NJ Grow award. Of this amount, $2,671,000 relates to the annual award earned in fiscal 2018, the cash proceeds of which are expected to be received during fiscal 2019. In December 2018, the Company received $2,829,000 cash proceeds, net of costs, from the receipt and subsequent sale of the tax credit certificate earned for fiscal 2017. During the three months ended May 4, 2019, the Company recognized a cost reduction related to the Grow NJ award in the amount of $617,000,

Income Taxes

Income Taxes	3 Months Ended
	May 04, 2019
Income Tax Disclosure [Abstract]
Income Taxes	1 3 . INCOME TAXES Accounting Standards Codification (“ASC”) Topic 740, Income Taxes In situations where a three-year cumulative loss condition exists, accounting standards limit the ability to consider projections of future results as positive evidence to assess the realizability of deferred tax assets. In fiscal 2016 the Company’s financial results reflected a three-year cumulative loss and consequently, in fiscal 2016 the Company recorded a non-cash charge as a valuation allowance against substantially all of its deferred tax assets. Three-year cumulative losses have continued since fiscal 2016, and the Company continues to record a valuation allowance against its deferred tax assets.

Equity Award Plans

Equity Award Plans	3 Months Ended
	May 04, 2019
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Equity Award Plans	1 4 . EQUITY AWARD PLANS In January 2006, the stockholders of the Company approved the adoption of the Amended and Restated 2005 Equity Incentive Plan (the “2005 Plan”) and, subsequently, have approved amendments to increase the number of issuable shares under the 2005 Plan. Under the 2005 Plan, employees, directors, consultants and other individuals who provide services to the Company may be granted awards in the form of stock options, stock appreciation rights, restricted stock, RSUs or deferred stock units. Up to 3,550,000 shares of the Company’s common stock may be issued in respect of awards under the 2005 Plan, as amended, with no more than 2,250,000 of those shares permitted to be issued in respect of restricted stock, RSUs, or deferred stock units granted under the 2005 Plan. Awards of stock options to purchase the Company’s common stock will have exercise prices as determined by the Compensation Committee of the Board of Directors but such exercise prices may not be lower than the fair market value of the stock on the date of grant. No stock options have been granted by the Company with an exercise price less than the fair market value of the Company’s common stock on the date of grant for any of the periods presented. The majority of the stock options issued under the 2005 Plan vest ratably over four-year periods and generally expire ten years from the date of grant, and restricted stock and time-based RSU awards issued under the 2005 Plan generally have restrictions that lapse ratably over periods ranging from one to four years however, awards with respect to up to 177,500 shares of our common stock may be granted under the 2005 Plan with a vesting period of less than one year. Performance-based awards issued under the 2005 Plan generally vest based upon the achievement of pre-established performance goals over a specified three-year period. The number of shares of our common stock that may be earned in respect of performance-based awards may be greater or less than the target number of shares granted based on the actual performance achieved. The non-executive chairman of the Company’s Board of Directors is granted 6,000 shares of restricted stock on an annual basis and each non-employee director, other than the non-executive chairman, and Christopher B. Morgan, of the Company’s Board of Directors is eligible for a grant of 4,000 shares of restricted stock on an annual basis, in each case that will generally vest one year from the date of grant. The Company issues new shares of common stock upon exercise of vested stock options. As of May 4, 2019, there were 834,231 shares of the Company’s common stock available for grants of awards under the 2005 Plan. Stock option activity for all plans was as follows: Outstanding Stock Options (in thousands) Weighted Average Exercise Price Weighted Average Remaining Life Aggregate Intrinsic Value (in thousands) Balance as of February 2, 2019 439 $ 6.06 Granted 45 2.33 Exercised — — Forfeited (41 ) 4.17 Expired — — Balance as of May 4, 2019 443 $ 5.85 8.3 — Exercisable as of May 4, 2019 161 $ 9.75 6.7 — The following table summarizes information about stock options outstanding as of May 4, 2019: Stock Options Outstanding Stock Options Exercisable Range of Exercise Prices Number Outstanding (in thousands) Weighted Average Remaining Life Weighted Average Exercise Price Number Exercisable (in thousands) Weighted Average Exercise Price $ 2.33 to $ 5.00 237 9.2 $ 2.63 43 $ 2.65 5.01 to 10.00 134 8.3 6.32 48 7.49 10.01 to 31.38 72 5.2 15.53 70 15.69 $ 2.33 to $31.38 443 8.3 $ 5.85 161 $ 9.75 The following table summarizes information about restricted stock and RSU activity for the 2005 Plan and includes grants of 113,326 PRSUs which is the number of shares of common stock that would be delivered upon vesting assuming that the target level of performance is achieved. If performance was achieved at the maximum level, 226,652 shares of common stock would be delivered in respect of such PRSU’s. Outstanding Restricted Shares (in thousands) Weighted Average Grant Date Fair Value Unvested as of February 2, 2019 606 $ 3.34 Granted 75 2.45 Vested (64 ) 2.72 Forfeited (100 ) 2.68 Unvested as of May 4, 2019 517 $ 3.26

Recent Accounting Pronouncement

Recent Accounting Pronouncements	3 Months Ended
	May 04, 2019
New Accounting Pronouncements And Changes In Accounting Principles [Abstract]
Recent Accounting Pronouncements	1 5 . RECENT ACCOUNTING PRONOUNCEMENTS Adopted In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), referred to hereafter as ASC 842 . ASC 842 affects any entity that enters into a lease, as that term is defined, and its guidance supersedes Topic 840, Leases . As it substantively relates to the Company, ASC 842 requires lessees to recognize a right-of-use asset (“ROU asset”) and a lease liability, initially measured at the present value of the lease payments, in the consolidated balance sheet. On February 3, 2019, the Company adopted ASC 842 using the modified retrospective method for all lease arrangements in effect at the beginning of the period of adoption. Results for periods beginning February 3, 2019 are presented under ASC 842, and prior period amounts were not restated and continue to be reported under the Company’s historical method of lease accounting, ASC 840, Leases. Adoption of ASC 842 had a material impact of the Company’s balance sheet as the result of recognizing ROU assets and lease liabilities for operating leases. There was no material impact to our consolidated statement of operations or cash flows and there was no impact to covenant compliance under our current debt agreements. Accounting for finance leases remained substantially unchanged. For leases that commenced prior to the effective date of ASC 842 the Company adopted practical expedients that allowed for retention of its previous assessment of the following: (i) whether a contract contained a lease, (ii) lease classification and (iii) initial direct costs. The Company also elected not to recognize ROU assets and lease liabilities for leases with a term of 12 months or less and to account for leases which have both lease and non-lease components as a single component. At the date of adoption, the Company recorded operating lease ROU assets of $135 million, operating lease liabilities of $159 million, primarily related to its retail real estate, distribution center and corporate office and a $2.6 million adjustment to accumulated deficit resulting from the impairment of certain operating lease ROU assets. Refer to Note 8. Leases for additional disclosures required by ASC 842. The Company determines if an arrangement is a lease at inception. ROU assets represent the Company’s right to use an underlying asset during the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the commencement of the lease based on the net present value of the fixed lease payments over the lease term. The lease term includes options to extend or terminate the lease when it is reasonably certain that we will exercise the option. ROU assets include prepaid lease payments, lease incentives received and capitalized lease costs. As the Company’s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on information available at the lease commencement date to determine the present value of lease payments. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense, while the expense for finance leases is recognized as depreciation and interest expense over the lease term. In August 2018, the FASB issued ASU 2018-15, Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	May 04, 2019
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingencies	1 6 . COMMITMENTS AND CONTINGENCIES From time to time, the Company is named as a defendant in legal actions arising from normal business activities. Litigation is inherently unpredictable, and although the amount of any liability that could arise with respect to currently pending actions cannot be accurately predicted, the Company does not believe that the resolution of any pending action will have a material adverse effect on its financial position, results of operations or liquidity. The Company has recently gained access to inspect inventory subject to a potential loss that occurred while the inventory was in transit to the Company’s distribution center. While still in the process of evaluating the inventory, the Company believes that it has insurance coverage in place to cover any potential loss, should such a loss occur.

Segment and Enterprise Wide Dis

Segment and Enterprise Wide Disclosures	3 Months Ended
	May 04, 2019
Segment Reporting [Abstract]
Segment and Enterprise Wide Disclosures	1 7 . SEGMENT AND ENTERPRISE WIDE DISCLOSURES Operating Segment . For purposes of the disclosure requirements for segments of a business enterprise, the Company has determined that its business is comprised of one operating segment: the design, manufacture and sale of maternity apparel and related accessories. While the Company offers a wide range of products for sale, the substantial portion of its products are initially distributed through the same distribution facilities, many of the Company’s products are manufactured at common contract manufacturer production facilities, the Company’s products are marketed through a common marketing department, and these products are sold to a similar customer base consisting of expectant mothers. Geographic Information . Geographic revenue information is allocated based on the country in which the products or services are sold, and in the case of international franchise revenues, on the location of the customer. Information concerning the Company’s operations by geographic area was as follows (in thousands): Three Months Ended May 4, 2019 May 5, 2018 Net Sales United States $ 90,646 $ 98,250 Foreign 3,567 4,977 May 4, 2019 February 2, 2019 Long-Lived Assets United States $ 49,995 $ 51,068 Foreign 1,078 1,228 Major Customers . For the periods presented, the Company did not have any one customer who represented more than 10% of its net sales.

Interest Expense, Net

Interest Expense, Net	3 Months Ended
	May 04, 2019
Banking And Thrift Interest [Abstract]
Interest Expense, Net	1 8 . INTEREST EXPENSE, NET Interest expense, net was comprised of the following (in thousands): Three Months Ended May 4, 2019 May 5, 2018 Interest expense $ 1,416 $ 1,158 Interest income (1 ) (1 ) Interest expense, net $ 1,415 $ 1,157

Recent Accounting Pronounceme_2

Recent Accounting Pronouncements (Policies)	3 Months Ended
	May 04, 2019
Accounting Policies [Abstract]
Adopted	Adopted In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), referred to hereafter as ASC 842 . ASC 842 affects any entity that enters into a lease, as that term is defined, and its guidance supersedes Topic 840, Leases . As it substantively relates to the Company, ASC 842 requires lessees to recognize a right-of-use asset (“ROU asset”) and a lease liability, initially measured at the present value of the lease payments, in the consolidated balance sheet. On February 3, 2019, the Company adopted ASC 842 using the modified retrospective method for all lease arrangements in effect at the beginning of the period of adoption. Results for periods beginning February 3, 2019 are presented under ASC 842, and prior period amounts were not restated and continue to be reported under the Company’s historical method of lease accounting, ASC 840, Leases. Adoption of ASC 842 had a material impact of the Company’s balance sheet as the result of recognizing ROU assets and lease liabilities for operating leases. There was no material impact to our consolidated statement of operations or cash flows and there was no impact to covenant compliance under our current debt agreements. Accounting for finance leases remained substantially unchanged. For leases that commenced prior to the effective date of ASC 842 the Company adopted practical expedients that allowed for retention of its previous assessment of the following: (i) whether a contract contained a lease, (ii) lease classification and (iii) initial direct costs. The Company also elected not to recognize ROU assets and lease liabilities for leases with a term of 12 months or less and to account for leases which have both lease and non-lease components as a single component. At the date of adoption, the Company recorded operating lease ROU assets of $135 million, operating lease liabilities of $159 million, primarily related to its retail real estate, distribution center and corporate office and a $2.6 million adjustment to accumulated deficit resulting from the impairment of certain operating lease ROU assets. Refer to Note 8. Leases for additional disclosures required by ASC 842. The Company determines if an arrangement is a lease at inception. ROU assets represent the Company’s right to use an underlying asset during the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the commencement of the lease based on the net present value of the fixed lease payments over the lease term. The lease term includes options to extend or terminate the lease when it is reasonably certain that we will exercise the option. ROU assets include prepaid lease payments, lease incentives received and capitalized lease costs. As the Company’s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on information available at the lease commencement date to determine the present value of lease payments. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense, while the expense for finance leases is recognized as depreciation and interest expense over the lease term. In August 2018, the FASB issued ASU 2018-15, Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract

Earnings Per Share ("EPS") (Tab

Earnings Per Share ("EPS") (Tables)	3 Months Ended
	May 04, 2019
Earnings Per Share [Abstract]
Summary of Basic EPS and Diluted EPS Calculations	The following tables summarize the Basic EPS and Diluted EPS calculations (in thousands, except per share amounts): Three Months Ended May 4, 2019 May 5, 2018 Net Income Shares EPS Net Income Shares EPS Basic EPS $ 130 13,825 $ 0.01 $ 214 13,839 $ 0.02 Incremental shares from the assumed exercise of outstanding stock options — — — — — — Incremental shares from the assumed lapse of restrictions on restricted stock and RSU awards — 76 — — 124 — Diluted EPS $ 130 13,901 $ 0.01 $ 214 13,963 $ 0.02

Inventories (Tables)

Inventories (Tables)	3 Months Ended
	May 04, 2019
Inventory Disclosure [Abstract]
Inventories	Inventories were comprised of the following (in thousands): May 4, 2019 February 2, 2019 Finished goods $ 71,992 $ 70,660 Work-in-progress 46 148 Raw materials 95 64 Total $ 72,133 $ 70,872

Accrued Expenses and Other Cu_2

Accrued Expenses and Other Current Liabilities (Tables)	3 Months Ended
	May 04, 2019
Payables And Accruals [Abstract]
Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities were comprised of the following (in thousands): May 4, 2019 February 2, 2019 Employee compensation and benefits $ 4,376 $ 6,741 Insurance, primarily self-insurance reserves 3,125 3,049 Sales and use taxes 3,086 2,737 Accrued expenses 3,073 4,561 Gift certificates and store credits 2,915 3,464 Product return reserve 2,530 2,078 Deferred revenue 1,713 2,435 Audit and legal 1,463 1,341 Deferred rent — 3,101 Other 2,327 1,549 Total $ 24,608 $ 31,056

Leases (Tables)

Leases (Tables)	3 Months Ended
	May 04, 2019
Lessee Disclosure [Abstract]
Schedule of Components of Lease Expense	For the three months ended May 4, 2019, the components of lease expense were as follows (in thousands): Fixed operating lease expense (1) $ 8,743 Variable operating lease expense 3,893 Total operating lease expense $ 12,636 (1) Includes short-term leases.
Schedule of Operating Lease Balances within Consolidated Balance Sheet, Weighted Average Remaining Lease Term and Weighted Average Discount Rates	The following table presents the operating lease balances within the Consolidated Balance Sheet, weighted average remaining lease term and weighted average discount rates related to the Company’s operating leases as of May 4, 2019 ($ in thousands): Lease Assets and Liabilities Classification Assets: Operating lease ROU assets Operating lease assets $ 128,065 Liabilities: Current: Operating lease liabilities Operating lease liabilities $ 32,327 Long-term: Operating lease liabilities Operating lease and other non-current liabilities 119,636 Total undiscounted operating lease liabilities $ 151,963 Weighted average remaining lease term 6.4 years Weighted average discount rate 7.40 %
Schedule of Maturity of Operating Lease Liabilities	The following table presents the maturity of the Company’s operating lease liabilities as of May 4, 2019 (in thousands): Remainder of Fiscal 2019 $ 32,864 2020 34,750 2021 28,555 2022 24,128 2023 20,969 Thereafter 53,693 Total operating lease payments 194,959 Less: Imputed interest 42,996 Total operating lease liabilities $ 151,963
Future Annual Minimum Operating Lease Payments	The following table presents future minimum lease payments as previously disclosed in our 2018 Annual Report on Form 10-K determined using the previous lease accounting standard. 2019 $ 36,417 2020 29,682 2021 21,142 2022 21,698 2023 15,995 Thereafter 48,462 Total operating lease liabilities $ 173,396
Schedule of Supplemental Cash Flow Information Related to Operating Leases	Supplemental cash flow information related to the Company’s operating leases for the three months ended May 4, 2019 (in thousands): Cash paid for amounts included in the measurement of operating lease liabilities $ 11,994 ROU assets obtained in exchange for operating lease liability 1,829

Net Sales (Tables)

Net Sales (Tables)	3 Months Ended
	May 04, 2019
Revenues [Abstract]
Schedule of Disaggregation of Company's Net Sales by Major Source	The following disaggregates the Company’s net sales by major source (in thousands): Three Months Ended May 4, 2019 May 5, 2018 Retail stores $ 56,464 $ 62,987 Leased departments 9,348 9,989 Total retail locations 65,812 72,976 E-commerce 22,672 25,482 Marketing partnerships 4,580 3,935 Wholesale and franchise 1,150 834 Total net sales $ 94,213 $ 103,227

Other Charges (Tables)

Other Charges (Tables)	3 Months Ended
	May 04, 2019
Other Charges Related To Management And Organizational Changes And Proxy Solicitation [Abstract]
Summary of Charges Incurred in Management and Organizational Changes and Proxy Solicitation	A summary of charges incurred in connection with management and organizational changes and the proxy solicitation is as follows (in thousands): Three Months Ended May 4, 2019 May 5, 2018 Management and organizational changes $ 662 $ 264 Proxy solicitation — 886 Total other charges $ 662 $ 1,150

Equity Award Plans (Tables)

Equity Award Plans (Tables)	3 Months Ended
	May 04, 2019
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Stock Option Activity for All Plans	Stock option activity for all plans was as follows: Outstanding Stock Options (in thousands) Weighted Average Exercise Price Weighted Average Remaining Life Aggregate Intrinsic Value (in thousands) Balance as of February 2, 2019 439 $ 6.06 Granted 45 2.33 Exercised — — Forfeited (41 ) 4.17 Expired — — Balance as of May 4, 2019 443 $ 5.85 8.3 — Exercisable as of May 4, 2019 161 $ 9.75 6.7 —
Summarizes Information about Stock Options Outstanding	The following table summarizes information about stock options outstanding as of May 4, 2019: Stock Options Outstanding Stock Options Exercisable Range of Exercise Prices Number Outstanding (in thousands) Weighted Average Remaining Life Weighted Average Exercise Price Number Exercisable (in thousands) Weighted Average Exercise Price $ 2.33 to $ 5.00 237 9.2 $ 2.63 43 $ 2.65 5.01 to 10.00 134 8.3 6.32 48 7.49 10.01 to 31.38 72 5.2 15.53 70 15.69 $ 2.33 to $31.38 443 8.3 $ 5.85 161 $ 9.75
Restricted Stock Activity	The following table summarizes information about restricted stock and RSU activity for the 2005 Plan and includes grants of 113,326 PRSUs which is the number of shares of common stock that would be delivered upon vesting assuming that the target level of performance is achieved. If performance was achieved at the maximum level, 226,652 shares of common stock would be delivered in respect of such PRSU’s. Outstanding Restricted Shares (in thousands) Weighted Average Grant Date Fair Value Unvested as of February 2, 2019 606 $ 3.34 Granted 75 2.45 Vested (64 ) 2.72 Forfeited (100 ) 2.68 Unvested as of May 4, 2019 517 $ 3.26

Segment and Enterprise Wide D_2

Segment and Enterprise Wide Disclosures (Tables)	3 Months Ended
	May 04, 2019
Segment Reporting [Abstract]
Operations by Geographic Area	Geographic Information . Geographic revenue information is allocated based on the country in which the products or services are sold, and in the case of international franchise revenues, on the location of the customer. Information concerning the Company’s operations by geographic area was as follows (in thousands): Three Months Ended May 4, 2019 May 5, 2018 Net Sales United States $ 90,646 $ 98,250 Foreign 3,567 4,977 May 4, 2019 February 2, 2019 Long-Lived Assets United States $ 49,995 $ 51,068 Foreign 1,078 1,228

Interest Expense, Net (Tables)

Interest Expense, Net (Tables)	3 Months Ended
	May 04, 2019
Banking And Thrift Interest [Abstract]
Interest Expense, Net	Interest expense, net was comprised of the following (in thousands): Three Months Ended May 4, 2019 May 5, 2018 Interest expense $ 1,416 $ 1,158 Interest income (1 ) (1 ) Interest expense, net $ 1,415 $ 1,157

Earnings Per Share ("EPS") and

Earnings Per Share ("EPS") and Dividends - Summary of Basic EPS and Diluted EPS Calculations (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	May 04, 2019	May 05, 2018
Earnings Per Share Diluted [Line Items]
Net Income	$ 130	$ 214
Average shares outstanding— Basic	13,825	13,839
Diluted shares	13,901	13,963
Basic EPS	$ 0.01	$ 0.02
Diluted EPS	$ 0.01	$ 0.02
Restricted Stock
Earnings Per Share Diluted [Line Items]
Incremental shares from the assumed lapse of restrictions on restricted stock and RSU awards	76	124

Earnings Per Share ("EPS") - Ad

Earnings Per Share ("EPS") - Additional Information (Details)	3 Months Ended
	May 04, 2019shares
Earnings Per Share Diluted [Line Items]
Options and unvested restricted stock	610,000
Common Stock
Earnings Per Share Diluted [Line Items]
Stock options and unvested restricted stock	959,000

Trade Receivables - Additional

Trade Receivables - Additional Information (Details) - USD ($) $ in Thousands	May 04, 2019	Feb. 02, 2019
Receivables [Abstract]
Trade receivables, allowance for doubtful accounts	$ 166	$ 166

Inventories - Inventories (Deta

Inventories - Inventories (Details) - USD ($) $ in Thousands	May 04, 2019	Feb. 02, 2019
Inventory Disclosure [Abstract]
Finished goods	$ 71,992	$ 70,660
Work-in-progress	46	148
Raw materials	95	64
Total	$ 72,133	$ 70,872

Accrued Expenses and Other Cu_3

Accrued Expenses and Other Current Liabilities - Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	May 04, 2019	Feb. 02, 2019
Payables and Accruals [Abstract]
Employee compensation and benefits	$ 4,376	$ 6,741
Insurance, primarily self-insurance reserves	3,125	3,049
Sales and use taxes	3,086	2,737
Accrued expenses	3,073	4,561
Gift certificates and store credits	2,915	3,464
Product return reserve	2,530	2,078
Deferred revenue	1,713	2,435
Audit and legal	1,463	1,341
Deferred rent		3,101
Other	2,327	1,549
Total	$ 24,608	$ 31,056

Line of Credit - Additional Inf

Line of Credit - Additional Information (Details) - USD ($)	Feb. 01, 2018	May 04, 2019	May 05, 2018	Feb. 02, 2019
Line Of Credit Facility [Line Items]
Minimum excess availability on Combined Loan Cap	10.00%	10.00%
Minimum amount excess availability on Combined Loan Cap	$ 7,000,000,000	$ 7,000,000
Payment of financing costs			$ 80,000
Outstanding borrowings under Credit Facility		26,200,000	15,200,000	$ 20,400,000
Letters of credit		6,297,000	7,327,000
Line of credit availability		$ 10,128,000	$ 20,223,000
Borrowings interest rate		4.53%	3.60%
Line of credit, outstanding borrowings		$ 27,509,000	$ 19,436,000
Line of credit borrowings during period		$ 32,300,000	$ 27,400,000
Senior Secured Revolving Credit Facility
Line Of Credit Facility [Line Items]
Credit facility, maximum borrowing capacity	50,000,000
Line of credit expiration date		Jan. 31, 2023
Unused line fee under the Credit Facility		0.25%
Credit Facility Description of Variable Rate Basis		The interest rate on outstanding borrowings is equal to, at the Company’s election, either 1) the lender’s base rate plus 0.50% or 2) a LIBOR rate plus 1.0%.
Deferred financing costs		$ 1,281,000
Senior Secured Revolving Credit Facility | Base Rate
Line Of Credit Facility [Line Items]
Applicable margin rate		0.50%
Senior Secured Revolving Credit Facility | London Interbank Offered Rate (LIBOR)
Line Of Credit Facility [Line Items]
Applicable margin rate		1.00%
Term Loan
Line Of Credit Facility [Line Items]
Loan available for borrowing	$ 25,000,000
Line of credit expiration date	Jan. 31, 2023
Credit Facility Description of Variable Rate Basis		The interest rate on the Term Loan is equal to a LIBOR rate plus 9.0%.
Term Loan | London Interbank Offered Rate (LIBOR)
Line Of Credit Facility [Line Items]
Applicable margin rate	9.00%

Long-Term Debt - Additional Inf

Long-Term Debt - Additional Information (Details) - USD ($)	Feb. 22, 2019	Feb. 01, 2018	Jun. 06, 2017	May 04, 2019	Jan. 31, 2015	Jul. 16, 2018	May 05, 2018
Debt Instrument [Line Items]
Minimum excess availability on Combined Loan Cap		10.00%		10.00%
Minimum amount excess availability on Combined Loan Cap		$ 7,000,000,000		$ 7,000,000
Principal outstanding				1,593,000
Sale and leaseback transaction, financing agreement period	24 months		3 years
Principal outstanding	$ 1,802,000			$ 1,114,000			$ 2,287,000
Monthly payments for first 24 months	$ 82,000		$ 123,000
Percentage of interest on equipment financing arrangement	8.16%
Sale and leaseback, transaction date				June 6, 2017
Sale and leaseback, description of assets				certain furniture, fixtures and software
Monthly payments under leaseback arrangement for 25 to 36 months			48,000
Sale and leaseback, payment terms				Monthly payments under the leaseback arrangement are $123,000 for the first 24 months and $48,000 for months 25 to 36.
Equipment Loan
Debt Instrument [Line Items]
Percentage of interest on equipment financing arrangement					3.38%
Principal outstanding under equipment note				$ 2,149,000			5,284,000
Equipment financing arrangement period				5 years
Monthly payments for equipment financing arrangement					$ 272,000
Debt instrument maturity date					Dec. 31, 2019
Term Loan
Debt Instrument [Line Items]
Loan available for borrowing		$ 25,000,000
Line of credit maturity date		Jan. 31, 2023
Long-term debt borrowed		$ 22,500,000
Additional loan available for borrowing		$ 2,500,000
Period of delivery to the lender		45 days
Additional loan amount borrowed						$ 2,500,000
Credit Facility Description of Variable Rate Basis				The interest rate on the Term Loan is equal to a LIBOR rate plus 9.0%.
Debt Instrument, frequency of periodic payment				Quarterly
Debt instrument, payment terms				The Term Loan can be prepaid at the Company's option subject to certain restrictions and subject to a prepayment premium as follows: 1) if the prepayment occurs on or prior to the second anniversary of the Closing Date, the greater of a) interest on the prepayment that would otherwise have been paid with the 24 month period following the Closing Date minus actual interest payments made through the prepayment date and b) 2% of the prepayment and 2) 2% of the prepayment amount if paid between the second and third anniversary of the Closing Date.
Debt Instrument, frequency of periodic payment, commencing date				Jul. 31, 2018
Dividends payment or share repurchases prohibition period				3 years
Deferred financing costs				$ 2,455,000
Principal outstanding				$ 23,750,000			$ 22,500,000
Proceeds from equipment financing transaction			$ 3,401,000
Term Loan | London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Applicable margin rate		9.00%
Term Loan | Minimum
Debt Instrument [Line Items]
Debt instruments, periodic payments, principal		$ 312,500
Term Loan | Maximum
Debt Instrument [Line Items]
Loan available for borrowing		$ 25,000,000

Leases - Additional Information

Leases - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	May 04, 2019	May 05, 2018
Lessee Lease Description [Line Items]
Description of option to extend, operating lease	Many of these leases include one or more renewal options which can extend the lease for up to an additional 15 years.
Operating lease, existence of option to extend	true
Description of option to terminate, operating lease	We also have short-term leases that can be terminated by the Company or by the landlord with notification periods as short as 30 days
Operating lease, existence of option to terminate	true
Operating lease, notice period required for termination	30 days
Rent expense		$ 12.8
Maximum
Lessee Lease Description [Line Items]
Operating lease, renewal term	15 years

Leases - Schedule of Components

Leases - Schedule of Components of Lease Expense (Details) $ in Thousands	3 Months Ended
	May 04, 2019USD ($)
Lessee Disclosure [Abstract]
Fixed operating lease expense	$ 8,743
Variable operating lease expense	3,893
Total operating lease expense	$ 12,636

Leases - Schedule of Operating

Leases - Schedule of Operating Lease Balances within Consolidated Balance Sheet, Weighted Average Remaining Lease Term and Weighted Average Discount Rates (Details) $ in Thousands	May 04, 2019USD ($)
Assets:
Operating lease ROU assets	$ 128,065
Current:
Operating lease liabilities	32,327
Long-term:
Operating lease liabilities	$ 119,636
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	dest:OperatingLeaseAndOtherNonCurrentLiabilities
Total undiscounted operating lease liabilities	$ 151,963
Weighted average remaining lease term	6 years 4 months 24 days
Weighted average discount rate	7.40%

Leases - Schedule of Maturity o

Leases - Schedule of Maturity of Operating Lease Liabilities (Details) $ in Thousands	May 04, 2019USD ($)
Operating Lease Liabilities Payments Due [Abstract]
Remainder of Fiscal 2019	$ 32,864
2020	34,750
2021	28,555
2022	24,128
2023	20,969
Thereafter	53,693
Total operating lease payments	194,959
Less: Imputed interest	42,996
Total operating lease liabilities	$ 151,963

Leases - Future Annual Minimum

Leases - Future Annual Minimum Operating Lease Payments (Details) $ in Thousands	Feb. 02, 2019USD ($)
Operating Leases Future Minimum Payments Due [Abstract]
2019	$ 36,417
2020	29,682
2021	21,142
2022	21,698
2023	15,995
Thereafter	48,462
Total operating lease liabilities	$ 173,396

Leases - Schedule of Supplement

Leases - Schedule of Supplemental Cash Flow Information Related to Operating Leases (Details) $ in Thousands	3 Months Ended
	May 04, 2019USD ($)
Lessee Disclosure [Abstract]
Cash paid for amounts included in the measurement of operating lease liabilities	$ 11,994
ROU assets obtained in exchange for operating lease liability	$ 1,829

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Details) - USD ($) $ in Thousands	May 04, 2019	Feb. 02, 2019	May 05, 2018
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Cash equivalents held by the Company	$ 4	$ 4
Outstanding borrowings under Credit Facility	$ 26,200	$ 20,400	$ 15,200
Term Loan | Minimum
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Annual variable interest rate	9.00%

Net Sales - Schedule of Disaggr

Net Sales - Schedule of Disaggregation of Company's Net Sales by Major Source (Details) - USD ($) $ in Thousands	3 Months Ended
	May 04, 2019	May 05, 2018
Disaggregation of Revenue [Line Items]
Total net sales	$ 94,213	$ 103,227
Retail Stores [Member]
Disaggregation of Revenue [Line Items]
Total net sales	56,464	62,987
Leased Departments [Member]
Disaggregation of Revenue [Line Items]
Total net sales	9,348	9,989
Total Retail Locations [Member]
Disaggregation of Revenue [Line Items]
Total net sales	65,812	72,976
E-commerce [Member]
Disaggregation of Revenue [Line Items]
Total net sales	22,672	25,482
Marketing Partnerships [Member]
Disaggregation of Revenue [Line Items]
Total net sales	4,580	3,935
Wholesale and Franchisee [Member]
Disaggregation of Revenue [Line Items]
Total net sales	$ 1,150	$ 834

Other Charges - Additional Info

Other Charges - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	May 04, 2019	May 05, 2018
Other Charges Related To Management And Organizational Changes And Proxy Solicitation [Abstract]
Charges related to management and organizational changes	$ 662	$ 264
Charges related to proxy solicitation		$ 886

Other Charges - Summary of Char

Other Charges - Summary of Charges Incurred in Management and Organizational Changes and Proxy Solicitation (Details) - USD ($) $ in Thousands	3 Months Ended
	May 04, 2019	May 05, 2018
Other Charges Related To Management And Organizational Changes And Proxy Solicitation [Abstract]
Management and organizational changes	$ 662	$ 264
Proxy solicitation		886
Total other charges	$ 662	$ 1,150

Government Incentives - Additio

Government Incentives - Additional Information (Details) $ in Thousands	1 Months Ended	3 Months Ended
	Dec. 31, 2018USD ($)	May 04, 2019USD ($)Job	May 05, 2018USD ($)	Feb. 02, 2019USD ($)
Government Incentive Assistance Program [Line Items]
Deferred tax assets		$ 3,314		$ 2,671
Grow New Jersey Assistance Program (Grow NJ)
Government Incentive Assistance Program [Line Items]
Income tax credits granted from state incentive package		$ 40,000
Transferrable income tax credit period		10 years
Government incentive assistance program award period		10 years
Project development, eligible amount per new full time job		$ 7
Government incentive assistance program annual award limit		$ 4,000
Award compliance period		5 years
Award Compliance Description		After the end of the ten-year Grow NJ award earnings period there is a five-year compliance period during which the Company must maintain the average of its annual eligible jobs certified during the preceding ten years or a pro-rata amount up to one-tenth of the previously awarded income tax credits would be subject to recapture and repayment to the State of New Jersey annually during the five-year compliance period.
Agreement to sell annual income tax credits awarded, Description		up to 100%
Deferred tax assets		$ 3,314		$ 2,671
Cash proceeds net of costs from government incentive assistance program	$ 2,829
Cost reduction related to award		$ 617	$ 710
Grow New Jersey Assistance Program (Grow NJ) | Minimum
Government Incentive Assistance Program [Line Items]
Government incentive assistance program number of eligible jobs | Job		100

Equity Award Plans - Additional

Equity Award Plans - Additional Information (Details) - shares	3 Months Ended
	May 04, 2019	May 05, 2018
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of stock options granted with exercise price less than fair market value on grant date	0	0
Non-employee director
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based payment award, vesting period	1 year
Restricted stock, shares granted	4,000
2005 Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options to be issued	3,550,000
Common stock shares issued, restricted stock units or deferred stock units	2,250,000
Common stock available for grant	834,231
Target cumulative performance-based restricted stock units available for future declaration	113,326
Maximum cumulative restricted stock units available for future declaration	226,652
2005 Plan | Employee Stock Option
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based payment award, vesting period	4 years
Share-based payment award, expiration period	10 years
2005 Plan | Restricted Stock
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based payment award, vesting period	1 year
Awards that may be issued	177,500
2005 Plan | Performance-Based Awards
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Performance period	3 years
2005 Plan | Maximum | Restricted Stock and Time-Based RSU
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based payment award, expiration period	4 years
2005 Plan | Minimum | Restricted Stock and Time-Based RSU
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based payment award, expiration period	1 year
Non-executive chairman
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based payment award, vesting period	1 year
Restricted stock, shares granted	6,000

Equity Award Plans - Stock Opti

Equity Award Plans - Stock Option Activity for All Plans (Details) shares in Thousands	3 Months Ended
	May 04, 2019$ / sharesshares
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Outstanding Stock Options, Beginning balance | shares	439
Outstanding Stock Options, Granted | shares	45
Outstanding Stock Options, Forfeited | shares	(41)
Outstanding Stock Options, Ending balance | shares	443
Outstanding Stock Options, Exercisable | shares	161
Weighted Average Exercise Price, Beginning balance | $ / shares	$ 6.06
Weighted Average Exercise Price, Granted | $ / shares	2.33
Weighted Average Exercise Price, Forfeited | $ / shares	4.17
Weighted Average Exercise Price, Ending balance | $ / shares	5.85
Weighted Average Exercise Price, Exercisable | $ / shares	$ 9.75
Weighted Average Remaining Life, Outstanding	8 years 3 months 18 days
Weighted Average Remaining Life, Exercisable	6 years 8 months 12 days

Equity Award Plans - Summarizes

Equity Award Plans - Summarizes Information about Stock Options Outstanding (Details) shares in Thousands	3 Months Ended
	May 04, 2019$ / sharesshares
2.33 to 5.00
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]
Range of Exercise Prices, lower range	$ 2.33
Range of Exercise Prices, upper range	$ 5
Stock Options Outstanding, Number Outstanding | shares	237
Stock Options Outstanding, Weighted Average Remaining Life	9 years 2 months 12 days
Stock Options Outstanding, Weighted Average Exercise Price	$ 2.63
Stock Options Exercisable, Number Exercisable | shares	43
Stock Options Exercisable, Weighted Average Exercise Price	$ 2.65
5.01 to 10.00
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]
Range of Exercise Prices, lower range	5.01
Range of Exercise Prices, upper range	$ 10
Stock Options Outstanding, Number Outstanding | shares	134
Stock Options Outstanding, Weighted Average Remaining Life	8 years 3 months 18 days
Stock Options Outstanding, Weighted Average Exercise Price	$ 6.32
Stock Options Exercisable, Number Exercisable | shares	48
Stock Options Exercisable, Weighted Average Exercise Price	$ 7.49
10.01 to 31.38
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]
Range of Exercise Prices, lower range	10.01
Range of Exercise Prices, upper range	$ 31.38
Stock Options Outstanding, Number Outstanding | shares	72
Stock Options Outstanding, Weighted Average Remaining Life	5 years 2 months 12 days
Stock Options Outstanding, Weighted Average Exercise Price	$ 15.53
Stock Options Exercisable, Number Exercisable | shares	70
Stock Options Exercisable, Weighted Average Exercise Price	$ 15.69
2.33 to 31.38
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]
Range of Exercise Prices, lower range	2.33
Range of Exercise Prices, upper range	$ 31.38
Stock Options Outstanding, Number Outstanding | shares	443
Stock Options Outstanding, Weighted Average Remaining Life	8 years 3 months 18 days
Stock Options Outstanding, Weighted Average Exercise Price	$ 5.85
Stock Options Exercisable, Number Exercisable | shares	161
Stock Options Exercisable, Weighted Average Exercise Price	$ 9.75

Equity Award Plans - Restricted

Equity Award Plans - Restricted Stock Activity (Details) shares in Thousands	3 Months Ended
	May 04, 2019$ / sharesshares
Restricted stock activity for the 2005 Plan
Outstanding Restricted Shares, Unvested, beginning balance | shares	606
Outstanding Restricted Shares, Granted | shares	75
Outstanding Restricted Shares, Vested | shares	(64)
Outstanding Restricted Shares, Forfeited | shares	(100)
Outstanding Restricted Shares, Unvested, ending balance | shares	517
Weighted Average Grant Date Fair Value, Unvested, beginning balance | $ / shares	$ 3.34
Weighted Average Grant Date Fair Value, Granted | $ / shares	2.45
Weighted Average Grant Date Fair Value, Vested | $ / shares	2.72
Weighted Average Grant Date Fair Value, Forfeited | $ / shares	2.68
Weighted Average Grant Date Fair Value, Unvested, ending balance | $ / shares	$ 3.26

Recent Accounting Pronounceme_3

Recent Accounting Pronouncements - Additional Information (Details) - USD ($) $ in Thousands	May 04, 2019	Feb. 03, 2019
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Operating lease, right-of-use asset	$ 128,065
Operating lease, liability	$ 151,963
ASU 2016-02
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Operating lease, right-of-use asset		$ 135,000
Operating lease, liability		159,000
Adjustment to accumulated deficit from impairment of certain operating lease ROU assets		$ 2,600

Segment and Enterprise Wide D_3

Segment and Enterprise Wide Disclosures - Additional Information (Details)	3 Months Ended
	May 04, 2019SegmentCustomer
Disclosure Segment And Enterprise Wide Disclosures Additional Information Detail [Abstract]
Number of operating segment | Segment	1
Number of customer who represented more than 10% of net sales | Customer	0

Segment and Enterprise Wide D_4

Segment and Enterprise Wide Disclosures - Operations by Geographic Area (Details) - USD ($) $ in Thousands	3 Months Ended
	May 04, 2019	May 05, 2018	Feb. 02, 2019
Net Sales
Net sales	$ 94,213	$ 103,227
United States
Net Sales
Net sales	90,646	98,250
Long-Lived Assets
Long-Lived Assets	49,995		$ 51,068
Foreign
Net Sales
Net sales	3,567	$ 4,977
Long-Lived Assets
Long-Lived Assets	$ 1,078		$ 1,228

Interest Expense, Net - Interes

Interest Expense, Net - Interest Expense, Net (Details) - USD ($) $ in Thousands	3 Months Ended
	May 04, 2019	May 05, 2018
Interest expense, net
Interest expense	$ 1,416	$ 1,158
Interest income	(1)	(1)
Interest expense, net	$ 1,415	$ 1,157